<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Pfizer Seeks Confidential Medical Journal Files</title>
	<atom:link href="http://www.pharmalot.com/2008/02/pfizer-seeks-confidential-medical-journal-files/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2008/02/pfizer-seeks-confidential-medical-journal-files/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Mon, 22 Mar 2010 07:25:28 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: Review confidentiality and related issues &#171; Suicyte Notes</title>
		<link>http://www.pharmalot.com/2008/02/pfizer-seeks-confidential-medical-journal-files/#comment-182488</link>
		<dc:creator>Review confidentiality and related issues &#171; Suicyte Notes</dc:creator>
		<pubDate>Thu, 28 Feb 2008 21:02:40 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/02/pfizer-seeks-confidential-medical-journal-files/#comment-182488</guid>
		<description>[...] can find extensive coverage of this incident in a number of blogs, including Pharmalot and The Futile Cycle. As can be expected, bloggers and most scientists I spoke to take side with [...]</description>
		<content:encoded><![CDATA[<p>[...] can find extensive coverage of this incident in a number of blogs, including Pharmalot and The Futile Cycle. As can be expected, bloggers and most scientists I spoke to take side with [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: The Futile Cycle &#187; Blog Archive &#187; Subverting the Review Process</title>
		<link>http://www.pharmalot.com/2008/02/pfizer-seeks-confidential-medical-journal-files/#comment-174677</link>
		<dc:creator>The Futile Cycle &#187; Blog Archive &#187; Subverting the Review Process</dc:creator>
		<pubDate>Sat, 23 Feb 2008 22:08:17 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/02/pfizer-seeks-confidential-medical-journal-files/#comment-174677</guid>
		<description>[...] Pharmalot, apparently Pfizer is going to court to try to force the NEJM to release its confidential reviews [...]</description>
		<content:encoded><![CDATA[<p>[...] Pharmalot, apparently Pfizer is going to court to try to force the NEJM to release its confidential reviews [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Chris</title>
		<link>http://www.pharmalot.com/2008/02/pfizer-seeks-confidential-medical-journal-files/#comment-174475</link>
		<dc:creator>Chris</dc:creator>
		<pubDate>Sat, 23 Feb 2008 18:29:32 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/02/pfizer-seeks-confidential-medical-journal-files/#comment-174475</guid>
		<description>It may backfire.  There's a pretty good chance that what they are going to find is over excessive "editing" by Pfizer itself, emails and mark-ups seeking to tone down the safety language and beef us efficacy.  Keep your eyes on this one, if the journal ends up producing I would not be surprised if no one looks good.  This is largely an area untouched because the FDA tries no to regulate legitimate scientific exchange (well actually the current FDA tries to avoid regulating anything) and because the editing process happens basically out of view.  No one is really monitoring the process.  I have no idea what's there but my 20 years of experience working with pharma medical depts tells me it will be interesting.</description>
		<content:encoded><![CDATA[<p>It may backfire.  There&#8217;s a pretty good chance that what they are going to find is over excessive &#8220;editing&#8221; by Pfizer itself, emails and mark-ups seeking to tone down the safety language and beef us efficacy.  Keep your eyes on this one, if the journal ends up producing I would not be surprised if no one looks good.  This is largely an area untouched because the FDA tries no to regulate legitimate scientific exchange (well actually the current FDA tries to avoid regulating anything) and because the editing process happens basically out of view.  No one is really monitoring the process.  I have no idea what&#8217;s there but my 20 years of experience working with pharma medical depts tells me it will be interesting.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Bob Freeman</title>
		<link>http://www.pharmalot.com/2008/02/pfizer-seeks-confidential-medical-journal-files/#comment-173061</link>
		<dc:creator>Bob Freeman</dc:creator>
		<pubDate>Fri, 22 Feb 2008 15:18:47 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/02/pfizer-seeks-confidential-medical-journal-files/#comment-173061</guid>
		<description>As a journal editor and reviewer for other refereed publications, I am appalled at the arrogance and bullying displayed by Pfizer and its attorneys.  Most certainly, I would go to jail before disclosing one iota of information.</description>
		<content:encoded><![CDATA[<p>As a journal editor and reviewer for other refereed publications, I am appalled at the arrogance and bullying displayed by Pfizer and its attorneys.  Most certainly, I would go to jail before disclosing one iota of information.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: www.worldpharmanews.net</title>
		<link>http://www.pharmalot.com/2008/02/pfizer-seeks-confidential-medical-journal-files/#comment-172937</link>
		<dc:creator>www.worldpharmanews.net</dc:creator>
		<pubDate>Fri, 22 Feb 2008 14:00:19 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/02/pfizer-seeks-confidential-medical-journal-files/#comment-172937</guid>
		<description>&lt;strong&gt;Pharmalot » Pfizer Seeks Confidential Medical Journal Files...&lt;/strong&gt;

In a blistering editorial in Science magazine, editor-in-chief Donald Kennedy notes that Pfizer has issued subpoenas to the New England Journal of Medicine in order to wade through confidential reviews of published studies of its Celebrex and Bextra pa...</description>
		<content:encoded><![CDATA[<p><strong>Pharmalot » Pfizer Seeks Confidential Medical Journal Files&#8230;</strong></p>
<p>In a blistering editorial in Science magazine, editor-in-chief Donald Kennedy notes that Pfizer has issued subpoenas to the New England Journal of Medicine in order to wade through confidential reviews of published studies of its Celebrex and Bextra pa&#8230;</p>
]]></content:encoded>
	</item>
</channel>
</rss>
